MAPT and Alzheimer disease: Speech production on the level of acoustic speech characteristics is affected by many neurodegenerative diseases, including Alzheimer’s disease (AD) [4–7], a disease clinically characterized by a gradual decline in cognition, and biologically defined by amyloid-beta (Aβ) accumulation and neurofibrillary tau tangles [8].